Federal contracts
$23Kcommitted so far
Belzutifan 40 mg
The Department of Veterans Affairs has committed $23K to Merck so far. It runs until Jun 16, 2026.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
125 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 15, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q4 2025 13F
279,686
255,813
−8.5%
Share count drives classification; reported value also moves with price
0.67%
Within the filing's reported positions, not the manager's total assets
125
For Q1 2026
Federal contracts
Belzutifan 40 mg
The Department of Veterans Affairs has committed $23K to Merck so far. It runs until Jun 16, 2026.
Federal contracts
Welireg (BELZUTIFAN) 40 mg
The Department of Veterans Affairs has committed $23K to Merck so far. It runs until May 22, 2026.
Insider filing
Traded May 29 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.